Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars

NCT01496846 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

201

Enrollment

OTHER

Sponsor class

Conditions

Irreversible Pulpitis

Interventions

DRUG: IANB Articaine
DRUG: SUP Articaine
DRUG: SUP Lidocaine

Sponsor

University of Michigan

Collaborators

[object Object]